From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Michael A. Jakupec Haralabos Zorbas Christian Hartinger Bernhard K. Keppler Stefanie Zorbas-Seifried |
| Publication date | February 28, 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |